J Med Drug Rev 2011;1;13-20 (Review-Artikel in deutscher Sprache) Patients with atrial fibrillation have a high risk for ischemic stroke and systemic embolism and usually receive vitamin K antagonists for antithrombotic therapy. However, effective therapy with warfarin is rather difficult due to several limiting factors: uncertain antithrombotic effect, narrow therapeutic […]